Three things to know:
1. Biogennix designs, manufactures and distributes bone graft substitutes for bone fusion procedures.
2. The company is expanding its sales team, manufacturing capacity and research and development program.
3. Its bone grafting products — Morpheus and osteoSPAN — are resorbable, osteoconductive scaffolds that are used for bone regeneration.
More articles on devices:
Misonix ultrasonic device earns CE Mark approval — 4 insights
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
